Diabetes adherence study halted after just one participant
NCT ID NCT06333080
First seen Apr 21, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study aimed to see if following the dosing instructions for oral semaglutide helps improve blood sugar control in people with type 2 diabetes who are already taking metformin. Only one person enrolled before the study was stopped early. The main focus was on changes in time spent in the target blood sugar range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Steno Diabetes Center North Denmark
Aalborg, 9000, Denmark
Conditions
Explore the condition pages connected to this study.